BIOSCIENCE NEUTRACEUTICALS, INC. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
BIOSCIENCE NEUTRACEUTICALS, INC. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $21.44 thousand as of 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-08-07
- 2014-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $21.44K.
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $16.70K.
- 2013-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $14.20K.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2014-06-30 | $21.44K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $16.70K 10-Q · filed 2014-06-20 |
| 2013-12-31 | $14.20K 10-Q · filed 2014-08-07 |